Bard Associates Inc. Sells 5,500 Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Bard Associates Inc. reduced its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 27.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,225 shares of the company’s stock after selling 5,500 shares during the period. Bard Associates Inc.’s holdings in Bioceres Crop Solutions were worth $86,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Fourth Sail Capital LP raised its stake in Bioceres Crop Solutions by 61.6% in the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after buying an additional 1,209,277 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after acquiring an additional 29,693 shares in the last quarter. Stifel Financial Corp raised its position in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Finally, Ping Capital Management Inc. boosted its stake in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after purchasing an additional 3,000 shares in the last quarter. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Lake Street Capital cut their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Canaccord Genuity Group cut their target price on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Oppenheimer lowered their price target on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $9.88.

Bioceres Crop Solutions Stock Up 1.8 %

NASDAQ:BIOX opened at $4.01 on Wednesday. The firm has a market capitalization of $251.47 million, a P/E ratio of 200.60 and a beta of 0.57. The company’s fifty day moving average price is $5.96 and its 200-day moving average price is $7.09. Bioceres Crop Solutions Corp. has a 1-year low of $3.69 and a 1-year high of $13.50. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.